Parse Biosciences, founded in 2018, is a biotechnology company that aims to provide researchers with single-cell solutions to streamline their experiments and discovery for objectives such as cancer treatment and stem cell therapy. Their Evercode products seek to use single-cell technology for gene capture at a greater scale and advanced data evaluation that strive to make it easier for researchers to quickly analyze results, all without having to use an instrument. Parse Biosciences is headquartered in Seattle, Washington.

Register for Details

For more details on financing and valuation for Parse Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Parse Biosciences

Forge green plus iconForge green minus icon

What is Parse Biosciences's IPO price?

The IPO price for Parse Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Parse Biosciences?

Parse Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Parse Biosciences share pre-IPO?

If you own Parse Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Parse Biosciences a publicly traded company?

Parse Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Parse Biosciences founded?

Parse Biosciences was founded in 2018.

Who are Parse Biosciences's major investors?

National Science Foundation
Janus Henderson Investors
Logos Capital
Soleus Capital
Sahsen Ventures
Saras Capital
Bioeconomy Capital
Vernon & Park Capital
Updated on: Dec 21, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.